JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB89

Anti-Rad50 抗体 [13B3/2C6]

Anti-Rad50 antibody [13B3/2C6]

5

(6 Reviews)

|

(59 Publications)

Mouse Monoclonal RAD50 antibody. Carrier free. Suitable for IP, ICC/IF, Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 59 publications. Immunogen corresponding to Recombinant Fragment Protein within Human RAD50 aa 1-450.

別名を表示する

DNA repair protein RAD50, hRAD50, RAD50

7 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)

Immunohistochemical analysis of paraffin embedded pc 3 xenograft tissue stained for Rad50 protein at nucleus with ab89 at a 1/200 dilution.

Antigen retrieval : Citrate buffer, pH 6.0, 15 min

Immunocytochemistry/ Immunofluorescence - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Rad50 antibody [13B3/2C6] (AB89)

Immunocytochemical analysis of 4% paraformaldehyde-fixed, HeLa cells labelling Rad50 with ab89 at 1/200 dilution (green). Phalloidin at a 1/200 dilution was used to counterstain the cytoskeleton (red).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)

ab89 (1μg/ml) staining RAD50 in human placenta, using an automated system (DAKO Autostainer Plus). Using this protocol there is strong nuclear staining.
Sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffer EDTA pH 9.0 in a DAKO PT link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that, for manual staining, optimization of primary antibody concentration and incubation time is recommended. Signal amplification may be required.

This image was generated using the ascites version of the product.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rad50 antibody [13B3/2C6] (AB89)

Immunohistochemical analysis of paraffin embedded human lung cancer tissue stained for Rad50 protein at nucleus with ab89 at a 1/100 dilution.

Antigen retrieval : Citrate buffer, pH 6.0, 15 min

Flow Cytometry - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Rad50 antibody [13B3/2C6] (AB89)

Overlay histogram showing HeLa cells stained with ab89 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab89, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

This image was generated using the ascites version of the product.

Western blot - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • WB

Unknown

Western blot - Anti-Rad50 antibody [13B3/2C6] (AB89)

This picture was kindly supplied as part of the reviews for ab214 and for ab89 submitted by Anya Polischouk.

The bands represent nuclear (N) and cytoplasmic (C) extract from human lung cancer cells (U1810).

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-Rad50 antibody [13B3/2C6] (ab89)

Predicted band size: 153 kDa

false

Western blot - Anti-Rad50 antibody [13B3/2C6] (AB89)
  • WB

AbReview4232****

Western blot - Anti-Rad50 antibody [13B3/2C6] (AB89)

This image is courtesy of an Abreview submitted by Philippe Szankasi on 24 February 2006.

This image was generated using the ascites version of the product.

All lanes:

Western blot - Anti-Rad50 antibody [13B3/2C6] (ab89) at 1/1000 dilution

All lanes:

50 ug Human HEK293 total cell lysate

Secondary

All lanes:

HRP conjugated Donkey Anti-Mouse IgG

Predicted band size: 153 kDa,57 kDa,68 kDa

Observed band size: 100 kDa,160 kDa,300 kDa,68 kDa

true

Exposure time: 30s

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

13B3/2C6

アイソタイプ

IgG1

軽鎖のタイプ

kappa

キャリアフリー

Yes

交差種

Human

アプリケーション

ICC/IF, IP, Flow Cyt, WB, IHC-P

applications

免疫原

Recombinant Fragment Protein within Human RAD50 aa 1-450. The exact immunogen used to generate this antibody is proprietary information.

Q92878

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/1000", "ICCIF-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/3000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/1000", "IHCP-species-notes": "<p></p>" } } }

製品の詳細

This product was changed from ascites to tissue culture supernatant on 01/02/2019. Please note that the dilutions may need to be adjusted accordingly. If you have any questions, please do not hesitate to contact our scientific support team.

Clone 2C6 recognizes Rad50, a 153kDa protein involved in DNA double strand break repair. Rad50 is associated with Mre11 and p95 (Nibrin) to form a multiprotein complex involved in the double strand break repair process.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification
精製に関する特記事項
Affinity purified by Protein G.
バッファー組成
pH: 7.4 Constituents: PBS
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Rad50 is an important component of the MRN complex with its partners MRE11 and NBS1. This protein plays an important role in DNA double-strand break repair and telomere maintenance. Rad50 also known by its molecular weight of approximately 153 kDa possesses ATPase activity that facilitates the bridging of DNA ends during repair processes. It is expressed in a variety of tissues with higher levels observed in rapidly dividing cells such as those found in testes and lymphoid organs.
Biological function summary

Rad50 contributes to genomic stability by participating in non-homologous end joining (NHEJ) and homologous recombination (HR) both of which are DNA repair mechanisms. It is part of the MRN complex a multi-protein assembly that detects DNA breaks and aids in processing and signaling them for repair. This complex acts at the early stages of DNA damage response assisting in the recruitment of other repair enzymes and proteins to the site of DNA lesions.

Pathways

Rad50 is integral to DNA damage response signaling and repair pathways like Ataxia Telangiectasia Mutated (ATM) signaling. The MRN complex activates ATM a kinase that phosphorylates key substrates involved in controlling cell cycle checkpoints and promoting repair of damaged DNA. This relationship positions Rad50 and its complex members as significant participants in maintaining cellular integrity by preventing the accumulation of genetic mutations.

Rad50 mutations have links to cancer development due to their effect on genomic instability. Deficiencies in Rad50 or the MRN complex can impair DNA repair leading to an increased risk for neoplastic transformations. Additionally Rad50 interactions with proteins such as p53 a tumor suppressor underline its potential role in the mechanisms behind cancers like breast and ovarian cancer. These connections highlight the importance of Rad50 in understanding disease progression and developing therapeutic strategies.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Component of the MRN complex, which plays a central role in double-strand break (DSB) repair, DNA recombination, maintenance of telomere integrity and meiosis (PubMed : 15064416, PubMed : 21757780, PubMed : 27889449, PubMed : 28134932, PubMed : 28867292, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). The MRN complex is involved in the repair of DNA double-strand breaks (DSBs) via homologous recombination (HR), an error-free mechanism which primarily occurs during S and G2 phases (PubMed : 15064416, PubMed : 21757780, PubMed : 27889449, PubMed : 28867292, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). The complex (1) mediates the end resection of damaged DNA, which generates proper single-stranded DNA, a key initial steps in HR, and is (2) required for the recruitment of other repair factors and efficient activation of ATM and ATR upon DNA damage (PubMed : 15064416, PubMed : 27889449, PubMed : 28867292, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). The MRN complex possesses single-strand endonuclease activity and double-strand-specific 3'-5' exonuclease activity, which are provided by MRE11, to initiate end resection, which is required for single-strand invasion and recombination (PubMed : 11741547, PubMed : 9590181, PubMed : 9651580, PubMed : 9705271). Within the complex, RAD50 is both required to bind DNA ends and hold them in close proximity and regulate the activity of MRE11 (PubMed : 11741547, PubMed : 12805565, PubMed : 28134932). RAD50 provides an ATP-dependent control of MRE11 by positioning DNA ends into the MRE11 active site : ATP-binding induces a large structural change from an open form with accessible MRE11 nuclease sites into a closed form (By similarity). The MRN complex is also required for DNA damage signaling via activation of the ATM and ATR kinases : the nuclease activity of MRE11 is not required to activate ATM and ATR (PubMed : 15064416, PubMed : 15790808, PubMed : 16622404). The MRN complex is also required for the processing of R-loops (PubMed : 31537797). In telomeres the MRN complex may modulate t-loop formation (PubMed : 10888888).
See full target information RAD50

文献 (59)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:6843 PubMed39122671

2024

Enhancing homology-directed repair efficiency with HDR-boosting modular ssDNA donor.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Ying Jin,Peng Zhang,Le-Le Liu,Xiang Zhao,Xiao-Qing Hu,Si-Zhe Liu,Ze-Kun Li,Qian Liu,Jian-Qiao Wang,De-Long Hao,Zhu-Qin Zhang,Hou-Zao Chen,De-Pei Liu

iScience 27:108925 PubMed38323009

2024

RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Matthew E Randolph,Marwa Afifi,Aparna Gorthi,Rachel Weil,Breelyn A Wilky,Joshua Weinreb,Paul Ciero,Natalie Ter Hoeve,Paul J van Diest,Venu Raman,Alexander J R Bishop,David M Loeb

International journal of molecular sciences 24: PubMed37446144

2023

Selective Killing of BRCA2-Deficient Ovarian Cancer Cells via MRE11 Blockade.

Applications

Unspecified application

Species

Unspecified reactive species

Adel Alblihy,Reem Ali,Mashael Algethami,Alison A Ritchie,Ahmed Shoqafi,Shatha Alqahtani,Katia A Mesquita,Michael S Toss,Paloma Ordóñez-Morán,Jennie N Jeyapalan,Lodewijk Dekker,Martina Salerno,Edgar Hartsuiker,Anna M Grabowska,Emad A Rakha,Nigel P Mongan,Srinivasan Madhusudan

NPJ precision oncology 6:51 PubMed35853939

2022

Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Adel Alblihy,Reem Ali,Mashael Algethami,Ahmed Shoqafi,Michael S Toss,Juliette Brownlie,Natalie J Tatum,Ian Hickson,Paloma Ordonez Moran,Anna Grabowska,Jennie N Jeyapalan,Nigel P Mongan,Emad A Rakha,Srinivasan Madhusudan

Molecular pharmacology 101:322-333 PubMed35273080

2022

Nuclear Ceramide Is Associated with Ataxia Telangiectasia Mutated Activation in the Neocarzinostatin-Induced Apoptosis of Lymphoblastoid Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Fujita,Makoto Taniguchi,Chieko Hashizume,Yoshibumi Ueda,Shota Sakai,Tadakazu Kondo,Mayumi Hashimoto-Nishimura,Kentaro Hanada,Takeo Kosaka,Toshiro Okazaki

NPJ breast cancer 7:143 PubMed34782604

2021

Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Adel Alblihy,Ahmed Shoqafi,Michael S Toss,Mashael Algethami,Anna E Harris,Jennie N Jeyapalan,Tarek Abdel-Fatah,Juliette Servante,Stephen Y T Chan,Andrew Green,Nigel P Mongan,Emad A Rakha,Srinivasan Madhusudan

Journal of cellular and molecular medicine 25:10961-10972 PubMed34734468

2021

Rad50 promotes ovarian cancer progression through NF-κB activation.

Applications

Unspecified application

Species

Unspecified reactive species

Yinuo Li,Shourong Wang,Peng Li,Yingwei Li,Yao Liu,Haiya Fang,Xiyu Zhang,Zhaojian Liu,Beihua Kong

Nucleic acids research 49:11666-11689 PubMed34718742

2021

ID3 promotes homologous recombination via non-transcriptional and transcriptional mechanisms and its loss confers sensitivity to PARP inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Ali Bakr,Joschka Hey,Gianluca Sigismondo,Chun-Shan Liu,Ahmed Sadik,Ashish Goyal,Alice Cross,Ramya Lakshmana Iyer,Patrick Müller,Max Trauernicht,Kersten Breuer,Pavlo Lutsik,Christiane A Opitz,Jeroen Krijgsveld,Dieter Weichenhan,Christoph Plass,Odilia Popanda,Peter Schmezer

The Journal of biological chemistry 297:101036 PubMed34343566

2021

Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng Cao,Peiyi Han,Ling Liu,Yiman Tang,Shanshan Tian,Kai Zhang,Lei Shi,Zhiqiang Liu,Dexiang Zhuo,Wenshu Ge,Wenchen Gong

Journal of molecular medicine (Berlin, Germany) 99:425-438 PubMed33484281

2021

3D culture conditions support Kaposi's sarcoma herpesvirus (KSHV) maintenance and viral spread in endothelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Tatyana Dubich,Anne Dittrich,Kristine Bousset,Robert Geffers,Guntram Büsche,Mario Köster,Hansjörg Hauser,Thomas F Schulz,Dagmar Wirth
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com